Brief: Prostatype Study Results To Be Presented At World's Top Urology Meeting
Aug 24 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE ® P-SCORE AND PROGNOSTIC EVALUATION IN PROSTATE
CANCER TO BE PRESENTED AT THE LARGEST UROLOGY MEETING IN THE
WORLD
* P-SCORE HAS SHOWN BETTER PREDICTION PERFORMANCE FOR
PROSTATE
CANCER-SPECIFIC DEATH AND METASTASIS THAN EAU RISK
CLASSIFICATION
Source text for Eikon: ID:nWkr1Gjmn7
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants